Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

851 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma.
de Groot S, Röttgering B, Gelderblom H, Pijl H, Szuhai K, Kroep JR. de Groot S, et al. Among authors: gelderblom h. Cancers (Basel). 2020 Nov 29;12(12):3568. doi: 10.3390/cancers12123568. Cancers (Basel). 2020. PMID: 33260481 Free PMC article. Review.
First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study.
Kroep JR, Ouali M, Gelderblom H, Le Cesne A, Dekker TJA, Van Glabbeke M, Hogendoorn PCW, Hohenberger P. Kroep JR, et al. Among authors: gelderblom h. Ann Oncol. 2011 Jan;22(1):207-214. doi: 10.1093/annonc/mdq338. Epub 2010 Jul 23. Ann Oncol. 2011. PMID: 20656792 Free PMC article.
Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation.
de Jonge MJ, Slingerland M, Loos WJ, Wiemer EA, Burger H, Mathijssen RH, Kroep JR, den Hollander MA, van der Biessen D, Lam MH, Verweij J, Gelderblom H. de Jonge MJ, et al. Among authors: gelderblom h. Eur J Cancer. 2010 Nov;46(16):3016-21. doi: 10.1016/j.ejca.2010.07.015. Epub 2010 Aug 26. Eur J Cancer. 2010. PMID: 20801016 Clinical Trial.
Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells.
Buddingh EP, Schilham MW, Ruslan SE, Berghuis D, Szuhai K, Suurmond J, Taminiau AH, Gelderblom H, Egeler RM, Serra M, Hogendoorn PC, Lankester AC. Buddingh EP, et al. Among authors: gelderblom h. Cancer Immunol Immunother. 2011 Apr;60(4):575-86. doi: 10.1007/s00262-010-0965-3. Epub 2011 Jan 15. Cancer Immunol Immunother. 2011. PMID: 21240486 Free PMC article.
Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?
Anninga JK, Gelderblom H, Fiocco M, Kroep JR, Taminiau AH, Hogendoorn PC, Egeler RM. Anninga JK, et al. Among authors: gelderblom h. Eur J Cancer. 2011 Nov;47(16):2431-45. doi: 10.1016/j.ejca.2011.05.030. Epub 2011 Jun 22. Eur J Cancer. 2011. PMID: 21703851 Review.
851 results